Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F De Lorenzo

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Artery|January 1, 1993
XbaI polymorphism of the apolipoprotein B gene in patients with hyperlipidemia and echo-Doppler evidence of arterial lesionsF De Lorenzo, P Rubba, A Monticelli, et al.
Clinical Pharmacology and Therapeutics|January 2, 2009
Impact of different low-dose ritonavir regimens on lipids, CD36, and adipophilin expressionS Collot-Teixeira, F De Lorenzo, L Waters, et al.
International Journal of Immunopathology and Pharmacology|October 14, 2009
Immunogenicity of allo-vesicle carrying ERBB2 tumor antigen for dendritic cell-based anti-tumor immunotherapyC Napoletano, A Rughetti, R Landi, et al.
Ecancermedicalscience|January 28, 2015
Report from the OECI Oncology Days 2014Wh van Harten, G Stanta, G Bussolati, et al.
ESMO Open|December 5, 2023
Confirmatory validation analysis of the PROFFIT questionnaire to assess financial toxicity in cancer patientsL Arenare, C Porta, D Barberio, et al.
Journal of Cancer Policy|October 6, 2025
Longitudinal validation of the PROFFIT questionnaire to assess financial toxicity in cancer patientsL Arenare, C Porta, D Barberio, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Artery|January 1, 1993
XbaI polymorphism of the apolipoprotein B gene in patients with hyperlipidemia and echo-Doppler evidence of arterial lesionsF De Lorenzo, P Rubba, A Monticelli, et al.
Clinical Pharmacology and Therapeutics|January 2, 2009
Impact of different low-dose ritonavir regimens on lipids, CD36, and adipophilin expressionS Collot-Teixeira, F De Lorenzo, L Waters, et al.
International Journal of Immunopathology and Pharmacology|October 14, 2009
Immunogenicity of allo-vesicle carrying ERBB2 tumor antigen for dendritic cell-based anti-tumor immunotherapyC Napoletano, A Rughetti, R Landi, et al.
Ecancermedicalscience|January 28, 2015
Report from the OECI Oncology Days 2014Wh van Harten, G Stanta, G Bussolati, et al.
ESMO Open|December 5, 2023
Confirmatory validation analysis of the PROFFIT questionnaire to assess financial toxicity in cancer patientsL Arenare, C Porta, D Barberio, et al.
Journal of Cancer Policy|October 6, 2025
Longitudinal validation of the PROFFIT questionnaire to assess financial toxicity in cancer patientsL Arenare, C Porta, D Barberio, et al.
Pageof 5